Want to join the conversation?
$COL 3Q15 10-Q: 3Q15-end: Cash and cash equivalents were $294MM, down 34.67% from $450MM at 3Q14-end. Net long-term debt was $1,667MM, up 0.24% from $1,663MM at 3Q14-end. YTD 2015: Total revenues increased 8% driven by ARINC acquisition and 8% increase in Commercial Systems revenues. Diluted EPS from continuing operations increased 17% to $3.81.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?